WO2025083568 - NOVEL SMALL-MOLECULE PROTEIN KINASE INHIBITORS FOR IMPLICATIONS IN CANCER TREATMENT
National phase entry is expected:
Publication Number
WO/2025/083568
Publication Date
24.04.2025
International Application No.
PCT/IB2024/060130
International Filing Date
16.10.2024
Title **
[English]
NOVEL SMALL-MOLECULE PROTEIN KINASE INHIBITORS FOR IMPLICATIONS IN CANCER TREATMENT
[French]
NOUVEAUX INHIBITEURS DE PROTÉINE KINASE À PETITES MOLÉCULES POUR IMPLICATIONS DANS LE TRAITEMENT DU CANCER
Applicants **
PILLAI UNIVERSAL LLC
PILLAI, Dr BASKARAN
M.G., Dinesh
Inventors
PILLAI, Dr BASKARAN
M.G., Dinesh
Priority Data
202341028323
18.10.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1958 | |
| EPO | Filing, Examination, Granting | 11551 | |
| Japan | Filing, Examination, Granting | 1937 | |
| South Korea | Filing, Examination, Granting | 1669 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,855
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention discloses a Novel Small-molecule protein kinase inhibitors for implications in cancer treatment The novel anti-cancer molecules comprises of structures in accordance with Formula (1) or any derivative thereof, pharmaceutically acceptable salt thereof, or combination thereof in which: R is Alkyl group with at least one carbon atom X is Oxo or alkenyl group[French]
La présente invention concerne de nouveaux inhibiteurs de protéine kinase à petites molécules pour des implications dans le traitement du cancer, les nouvelles molécules anticancéreuses comprenant des structures conformes à la formule (1) ou un dérivé quelconque de celles-ci, un sel pharmaceutiquement acceptable de celles-ci, ou une combinaison de celles-ci dans lesquelles : R représente un groupe alkyle comprenant au moins un atome de carbone, X représente un groupe oxo ou alcényle.